Overview

Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.

Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Assessment of sedative effects of dexmedetomidine and propofol on the clinical course of delirium and neuroinflammation in patients with SIRS using CAM-ICU scale and protein S100b in serum.
Phase:
Phase 4
Details
Lead Sponsor:
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
Treatments:
Dexmedetomidine
Propofol